WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
฿ 5,20
0,00%
(0,00) 1D
15 okt, 16:40:00 GMT+7 · THB
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor WUXI06 genereren…
Openen
฿ 5,25
Hoog
฿ 5,35
Laag
฿ 5,05
Beursw.
197,28 mld.
Gem. vol.
93,60K
Volume
288,50K
52 wk hoog
฿ 6,25
52 wk laag
฿ 3,02
Uitstaande aandelen
4,12 mld.
Aantal medewerkers
15K
Openen
฿ 5,25
Hoog
฿ 5,35
Laag
฿ 5,05
Beursw.
197,28 mld.
Gem. vol.
93,60K
Volume
288,50K
52 wk hoog
฿ 6,25
52 wk laag
฿ 3,02
Uitstaande aandelen
4,12 mld.
Aantal medewerkers
15K
Nieuwsartikelen
Van webbronnen en nieuwspartners
MarketScreener Nederland
·
11 uur geleden
S&P 500 sluit hoger nu handelaren de overstap maken van AI naar gezondheidszorg
MarketScreener Nederland
·
11 uur geleden
Amerikaanse aandelenindices trekken zich niets aan van hoge producenteninflatie, terwijl obligatierentes sterk dalen
Vietnam.vn
·
6 uur geleden
Kort nieuws 16-10: Dow Jones stijgt met meer dan 550 punten door dalende obligatierentes, PV Power schat de winst over 9 maanden op meer dan 5.400 miljard VND
MarketScreener Nederland
·
18 uur geleden
VS: index van de New York Fed overtreft de verwachtingen ruimschoots
Profiel
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Over Wuxi Biologics (Cayman) Inc. KKPS DR